Repare Therapeutics (NASDAQ:RPTX) Rating Reiterated by HC Wa

Repare Therapeutics (NASDAQ:RPTX – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research report issued on Thursday, Benzinga reports. They presently have a $10.00 target price on the stock. HC Wainwright’s price target would indicate a potential upside of 187.36% from the stock’s previous close. Separately, […]

Related Keywords

Canada , United States , , Repare Therapeutics Inc , Exchange Traded Concepts , Harbor Capital Advisors Inc , Repare Therapeutics Company Profile , Connor Clark Lunn Investment Management Ltd , Blackstone Inc , Raymond James Financial Services Advisors Inc , Repare Therapeutics , Get Free Report , Bloom Burton , James Financial Services Advisors , Lunn Investment Management , Traded Concepts , Harbor Capital Advisors , Capital Advisors , Therapeutics Inc , Repare Therapeutics Daily ,